T1	Participants 13 37	gastrointestinal cancer:
T2	Participants 42 98	Southeastern Cancer Study Group experience, 1979 to 1983
T3	Participants 118 141	gastrointestinal cancer
T4	Participants 202 288	1979 to 1983 at 30 member institutions of the Southeastern Cancer Study Group (SECSG).
T5	Participants 398 413	1,087 patients.